Fig. 5From: Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The NetherlandsCost-effectiveness acceptability curve. The blue line represents the WTP threshold of €20,000. ICER incremental cost-effectiveness ratioBack to article page